Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Walgreens Closes Acquisition Of USA Drug Pharmacy Chain - Quick Facts

RELATED NEWS
Trade WAG now with 
9/17/2012 3:40 PM ET

Walgreen Co.(WAG: Quote) announced Monday that it has completed its purchase of a regional drugstore chain in the mid-South region of the United States from Stephen LaFrance Holdings Inc. and members of the LaFrance family.

The transaction includes 144 stores that operate under the USA Drug, Super D Drug, May's Drug, Med-X and Drug Warehouse names located in Arkansas, Kansas, Mississippi, Missouri, New Jersey, Oklahoma and Tennessee.

The acquisition also includes corporate offices, a distribution center located in Pine Bluff, Ark., and a wholesale and private brand business, for a total of approximately $438 million subject to adjustment in certain circumstances. The chain recorded sales of $825 million in 2011.

Click here to receive FREE breaking news email alerts for Walgreen Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
NASA's Cassini spacecraft, now exploring Saturn, will take a picture of Earth from a distance of hundreds of millions of miles on July 19. NASA is inviting the public to help acknowledge the historic interplanetary portrait as it is being taken. Earth will appear as a small, pale blue dot between the rings of Saturn in the image, which will be part of a mosaic, or multi-image portrait, of the A leading indicator of Australian economic activity continued to signal above-trend growth for the economy in the coming quarters, a report from Westpac and Melbourne Institute showed Wednesday. The annualized growth rate of the leading index, which indicates the likely pace of economic activity three to nine months into the future, was 5.4 percent in April, comfortably above its long term trend. Publishing and design software maker Adobe Systems Inc. said Tuesday after the markets closed that its second quarter profit fell 66% from last year, hurt by lower revenue as well as higher costs and expenses. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations and its quarterly revenue was in line with analysts' forecast.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.